Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.3B
Gross Profit 888.0M 65.96%
Operating Income 128.0M 9.51%
Net Income 106.7M 7.93%
EPS (Diluted) $1.04

Balance Sheet Metrics

Total Assets 3.4B
Total Liabilities 1.4B
Shareholders Equity 2.0B
Debt to Equity 0.73

Cash Flow Metrics

Operating Cash Flow 117.6M
Free Cash Flow 215.4M

Revenue & Profitability Trend

Premier Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue1.3B1.3B1.4B1.7B1.3B
Cost of Goods Sold458.3M439.8M547.9M883.8M432.8M
Gross Profit888.0M896.3M885.0M837.3M866.8M
Operating Expenses712.8M606.1M581.0M535.7M437.7M
Operating Income128.0M242.1M260.1M256.9M373.6M
Pre-tax Income149.8M250.0M326.9M250.6M383.7M
Income Tax43.1M75.1M58.6M-53.9M92.6M
Net Income106.7M174.9M268.3M304.6M292.2M
EPS (Diluted)$1.04$1.46$2.19$2.22$2.04

Income Statement Trend

Premier Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets748.0M641.6M645.6M782.3M618.4M
Non-Current Assets2.7B2.7B2.7B2.7B2.3B
Total Assets3.4B3.4B3.4B3.5B2.9B
Liabilities
Current Liabilities746.6M815.5M753.1M716.8M496.1M
Non-Current Liabilities692.7M221.7M355.1M576.2M2.3B
Total Liabilities1.4B1.0B1.1B1.3B2.8B
Equity
Total Shareholders Equity2.0B2.3B2.2B2.2B139.3M

Balance Sheet Composition

Premier Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income106.7M174.9M268.3M304.6M291.1M
Operating Cash Flow117.6M426.7M520.4M401.1M348.6M
Investing Activities
Capital Expenditures-81.2M-82.3M-87.4M-88.9M-94.4M
Investing Cash Flow-68.5M-273.6M-139.4M-174.6M-222.3M
Financing Activities
Dividends Paid-95.2M-100.2M-96.5M-102.8M-48.9M
Financing Cash Flow-407.7M-578.3M-635.6M-437.4M-125.6M
Free Cash Flow215.4M362.2M356.8M318.5M255.1M

Cash Flow Trend

Premier Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 21.46
Forward P/E 16.46
Price to Book 1.18
Price to Sales 1.52
PEG Ratio 16.46

Profitability Ratios

Profit Margin 4.96%
Operating Margin 18.45%
Return on Equity 6.85%
Return on Assets 4.05%

Financial Health

Current Ratio 0.66
Debt to Equity 19.35
Beta 0.56

Per Share Data

EPS (TTM) $1.02
Book Value per Share $18.50
Revenue per Share $13.01

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
pinc1.9B21.461.186.85%4.96%19.35
Veeva Systems 46.0B59.927.3914.06%27.34%1.24
Ge Healthcare 32.6B14.953.5526.44%11.03%97.52
Certara 1.7B104.001.56-0.25%-0.67%28.51
Schrodinger 1.5B44.394.05-43.33%-83.39%31.15
Omnicell 1.3B61.671.061.73%1.87%30.69

Financial data is updated regularly. All figures are in the company's reporting currency.